New Publication in Vaccine Highlights Preclinical Results of Vaxart's Mucosal Chikungunya Vaccine - Argus Press

New Publication in Vaccine Highlights Preclinical Results of Vaxart's Mucosal Chikungunya Vaccine  Argus Press

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--May 29, 2019--. Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral ...



Comments

Popular posts from this blog

Washtenaw Co. sees sharp increase in whooping cough cases - Detroit News